SEARCH

SEARCH BY CITATION

References

  • 1
    Prendiville W, Cullimore J, Norman S. Large loop excision of the transforming zone (LLETZ): a new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1989;96:105460.
  • 2
    Lindeque BG. Management of cervical premalignant lesions. Best Pract Res Clin Obstet Gynaecol 2005;19:54561.
  • 3
    Fogle RH, Spann CO, Easley KA, Basil JB. Predictors of cervical dysplasia after the loop electrosurgical excision procedure in an inner-city population. J Reprod Med 2004;49:4816.
  • 4
    Gardeil F, Barry-Walsh C, Prendiville W, Clinch J, Turner MJ. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol 1997;89:41922.
  • 5
    Dietrich CS, Yancey M, Miyazawa K, Williams D, Farley J. Risk factors for early cytologic abnormalities after loop electrosurgical excision procedure. Obstet Gynecol 2002;99:18892.
  • 6
    Livasy CA, Moore DT, Van Le L. The clinical significance of a negative loop electrosurgical cone biopsy for high-grade dysplasia. Obstet Gynecol 2004;104:2504.
  • 7
    Carter J, Sim J, Land R, Dalrymple C, Abdel-Hadi M, Pather S. Recurrence after treatment for high-grade dysplasia: should we modify our post-treatment surveillance protocols? Aust N Z J Obstet Gynaecol 2006;46:3602.
  • 8
    Alonso I, Torne A, Puig-Tintore LM et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 2006;103:6316.
  • 9
    Brockmeyer AD, Wright JD, Gao F, Powell MA. Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure. Am J Obstet Gynecol 2005;192:137981.
  • 10
    Tangtrakul S, Linasmita V, Israngura N, Srisupundit S, Bullangpoti S, Wilailak S. Detection of residual disease by cytology in patients with cervical intraepithelial neoplasia III post-large loop excision of the transformation zone. J Obstet Gynaecol Res 2002;28:958.
  • 11
    Felix JC, Muderspach LI, Duggan BD, Roman LD. The significance of positive margins in loop electrosurgical cone biopsies. Obstet Gynecol 1994;84:9961000.
  • 12
    Murdoch JB, Morgan PR, Lopes A, Monaghan JM. Histological incomplete excision of CIN after large loop excision of the transformation zone (LLETZ) merits careful follow-up, not retreatment. Br J Obstet Gynaecol 1992;99:9903.
  • 13
    Robinson WR, Lund ED, Adams J. The predictive value of LEEP specimen margin status for residual/recurrent cervical intraepithelial neoplasia. Int J Gynecol Cancer 1998;8:10912.
  • 14
    Johnson N, Khalili M, Hirschowitz L, Ralli F, Porter R. Predicting residual disease after excision of cervical dysplasia. BJOG 2003;110:9525.
  • 15
    Zaitoun AM, McKee G, Coppen MJ, Thomas SM, Wilson PO. Completeness of excision and follow-up cytology in patients treated with loop excision biopsy. J Clin Pathol 2000;53:1916.
  • 16
    Jain S, Tseng CJ, Horng SG, Soong YK, Pao CC. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 2001;82:17780.
  • 17
    Skinner EN, Gehrig PA, Van Le L. High-grade squamous intraepithelial lesions: abbreviating posttreatment surveillance. Obstet Gynecol 2004;103:48892.
  • 18
    Flannelly G, Bolger B, Fawzi H, De Lopes AB, Monaghan JM. Follow-up after LLETZ: could schedules be modified according to risk of recurrence? BJOG 2001;108:102530.
  • 19
    Sarian LO, Derchain SF, Pitta Dda R, Morais SS, Rabelo-Santos SH. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 2004;31:2704.
  • 20
    Verguts J, Bronselaer B, Donders G et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG 2006;113:13037.
  • 21
    Bollen LJ, Tjong-A-Hung SP, Van Der Velden J et al. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 1999;72:199201.
  • 22
    Lin CT, Tseng CJ, Lai CH et al. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 2001;184:9405.
  • 23
    Solomon D, Davey D, Kuman R et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:21149.
  • 24
    Zlatkov V, Kostova P. New revision of the international colposcopic terminology: Barcelona—2002. Akush Ginekol (Sofiia) 2003;42:446.
  • 25
    Paraskevaidis E, Arbyn M, Sotiriadis A et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev 2004;30:20511.
  • 26
    Soutter WP, De Barros Lopes A, Fletcher A et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:97880.